Limertinib diTFA

SI-7846

Limertinib diTFA, >98% (HPLC)

Synonyms : ASK-120067 diTFA

IUPAC Name : N-(5-((5-Chloro-4-(naphthalen-2-ylamino)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide bis(trifluoroacetate)

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Limertinib diTFA is a third‑generation, irreversible EGFR inhibitor that exhibits high potency against the T790M resistance mutation (IC₅₀ = 0.3 nM) and significantly lower activity toward wild‑type EGFR (IC₅₀= 6.0 nM). It is a valuable tool for investigating EGFR‑driven non‑small cell lung cancer.

References : Zhang T. et al.: Mol. Cancer, 19(1), 90, 2020.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.